Abstract:Antibodies with high targeting capability after being labelled by quantum dots (QDs) have been of great importance for in vitro diagnostic, cellular imaging and in vivo theranostic applications. However, such work concentrating on the conjugation of QDs and antibodies is still insufficient. It is encouraged to develop reliable bioconjugation strategies to improve detection sensitivity of QD-antibody bioconjugates. In this study, two bioconjugation approaches were used for antibody and QDs covalent coupling. Their detection sensitivity was parallelly determined and compared. It was experimentally found that succinimidyl valerate-PEG-maleimide (SMPEG) as the cross linker for oriented bioconjugation of antibodies to QDs with a flexible spacer arm can significantly improve the detection sensitivity of the resulting QD-antibody bioconjugates, compared with those prepared with traditional carbodiimide chemistry using EDC center dot HCl as the cross linker. Gel electrophoresis suggests antibodies can be successfully conjugated with QDs by both the EDC method and the SMPEG method, but immunofiltration assay shows QD-antibody bioconjugates obtained by the SMPEG strategy have lower detection limits and better linear scope patterns for in vitro molecular diagnosis. In vitro cancer cell imaging further shows that QD-antibody bioconjugates prepared by the SMPEG strategy have superior cell targeting capability without observable nonspecific binding, while the EDC-mediated QD-antibody bioconjugates have low signal to noise ratios with obvious nonspecific cellular binding. Moreover, the number of antibodies conjugated on the surface of QDs was determined by the chemiluminescent dot blot assay, showing 2.13 +/- 0.5 and 0.76 +/- 0.2 of antibodies per QD by EDC-mediated and SMPEG-mediated coupling, respectively. It further verifies that the SMPEG-mediated coupling strategy can significantly maintain the biological activity of the linked antibodies, even though it has low labelling efficiency. It could be therefore claimed that oriented bioconjugation via the SMPEG coupling strategy is favored by immunoassays, with improved detection sensitivity.

Highly robust and optimized conjugation of antibodies to nanoparticles using quantitatively validated protocols

Versatile and Robust method for Antibody Conjugation to Nanoparticles with High Targeting Efficiency

A Versatile Chemo-Enzymatic Conjugation Approach Yields Homogeneous and Highly Potent Antibody-Drug Conjugates.

Antibody quantum dot conjugates developed via copper-free click chemistry for rapid analysis of biological samples using a microfluidic microsphere array system.

Robust Strategy for Antibody-Polymer-Drug Conjugation: Significance of Conjugating Orientation and Linker Charge on Targeting Ability.

Assessing the activity of antibodies conjugated to upconversion nanoparticles for immunolabeling

Fabrication and Verification of Conjugated AuNP-Antibody Nanoprobe for Sensitivity Improvement in Electrochemical Biosensors

Antibody-oriented strategy and mechanism for the preparation of fluorescent nanoprobes for fast and sensitive immunodetection.

Improving detection sensitivity by oriented bioconjugation of antibodies to quantum dots with a flexible spacer arm for immunoassay

Strategies for Precise Engineering and Conjugation of Antibody Targeted-nanoparticles for Cancer Therapy

Linker-free conjugation and specific cell targeting of antibody functionalized iron-oxide nanoparticles

Microfluidics-assisted conjugation of chitosan-coated polymeric nanoparticles with antibodies: Significance in drug release, uptake, and cytotoxicity in breast cancer cells

Controlling colloidal stability of silica nanoparticles during bioconjugation reactions with proteins and improving their longer-term stability, handling and storage

Impact of conjugation strategies for targeting of antibodies in gold nanoparticles for ultrasensitive detection of 17β-estradiol

Site-directed Conjugation of Single-Stranded DNA to Affinity Proteins: Quantifying the Importance of Conjugation Strategy

Controlling Conjugated Antibodies at the Molecular Level for Active Targeting Nanoparticles Toward HER2-Positive Cancer Cells

Precision Modification of Native Antibodies

Click‐on Antibody Fragments for Customisable Targeted Nanomedicines – Site‐specific Tetrazine and Azide Functionalisation through Non‐canonical Amino Acid incorporation

Enhanced Resonance Light Scattering of Antibody Covalently Conjugated Gold Nanoparticles Due to Antigen-Antibody Interaction Induced Aggregation

Conjugation Chemistry Markedly Impacts Toxicity and Biodistribution of Targeted Nanoparticles, Mediated by Complement Activation

A Robust and Scalable Method to Crosslink Antibodies and Proteins